Literature DB >> 24037979

Aiming for a better understanding and management of cancer-related fatigue.

Elisabeth C W Neefjes1, Maurice J D L van der Vorst, Susanne Blauwhoff-Buskermolen, Henk M W Verheul.   

Abstract

Cancer-related fatigue (CRF) is a serious symptom of patients with cancer and deteriorates their daily quality of life. Whereas fatigue is a common problem in the general population, with a prevalence of about 30%, up to 99% of patients with cancer have fatigue of more intense severity. CRF is directly related to the biology of cancer, but it can also be caused by anticancer treatment. We reviewed current evidence about the potential pathophysiological mechanisms causing CRF. Clinical methods to determine the presence and severity of CRF and potential treatment options to reduce CRF will be discussed. After reading this review, the reader will have knowledge of the current understanding of CRF and will be able to give evidence-based advice to patients with CRF.

Entities:  

Keywords:  Drug therapy; Fatigue; Methylphenidate; Modafinil; Neoplasms; Questionnaires

Mesh:

Year:  2013        PMID: 24037979      PMCID: PMC3805156          DOI: 10.1634/theoncologist.2013-0076

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  132 in total

Review 1.  Central proinflammatory cytokines and pain enhancement.

Authors:  Julie Wieseler-Frank; Steven F Maier; Linda R Watkins
Journal:  Neurosignals       Date:  2005

2.  The situational fatigue scale: a different approach to measuring fatigue.

Authors:  Chien-Ming Yang; Chih-Hsing Wu
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

Review 3.  Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.

Authors:  Kathryn H Schmitz; Jeremy Holtzman; Kerry S Courneya; Louise C Mâsse; Sue Duval; Robert Kane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

4.  Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients.

Authors:  J Paul Monk; Gary Phillips; Ross Waite; John Kuhn; Larry J Schaaf; Gregory A Otterson; Denis Guttridge; Chris Rhoades; Manisha Shah; Tamara Criswell; Michael A Caligiuri; Miguel A Villalona-Calero
Journal:  J Clin Oncol       Date:  2006-04-20       Impact factor: 44.544

5.  Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.

Authors:  Eduardo Bruera; Vicente Valero; Larry Driver; Loren Shen; Jie Willey; Tao Zhang; J Lynn Palmer
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

6.  Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment.

Authors:  A Shafqat; L H Einhorn; N Hanna; G W Sledge; A Hanna; B E Juliar; P Monahan; S Bhatia
Journal:  Ann Oncol       Date:  2005-05-26       Impact factor: 32.976

Review 7.  A systematic review of the scales used for the measurement of cancer-related fatigue (CRF).

Authors:  O Minton; P Stone
Journal:  Ann Oncol       Date:  2008-08-04       Impact factor: 32.976

8.  Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.

Authors:  Sriram Yennurajalingam; Susan Frisbee-Hume; J Lynn Palmer; Marvin O Delgado-Guay; Janet Bull; Alexandria T Phan; Nizar M Tannir; Jennifer Keating Litton; Akhila Reddy; David Hui; Shalini Dalal; Lisa Massie; Suresh K Reddy; Eduardo Bruera
Journal:  J Clin Oncol       Date:  2013-07-29       Impact factor: 44.544

9.  Bupropion sustained release treatment reduces fatigue in cancer patients.

Authors:  Jodi L Cullum; Agnieszka E Wojciechowski; Guy Pelletier; J Steven A Simpson
Journal:  Can J Psychiatry       Date:  2004-02       Impact factor: 4.356

10.  Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.

Authors:  Eduardo Bruera; Sriram Yennurajalingam; J Lynn Palmer; Pedro E Perez-Cruz; Susan Frisbee-Hume; Julio A Allo; Janet L Williams; Marlene Z Cohen
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

View more
  24 in total

1.  Cancer-related fatigue and associated disability in post-treatment cancer survivors.

Authors:  Jennifer M Jones; Karin Olson; Pamela Catton; Charles N Catton; Neil E Fleshner; Monika K Krzyzanowska; David R McCready; Rebecca K S Wong; Haiyan Jiang; Doris Howell
Journal:  J Cancer Surviv       Date:  2015-04-16       Impact factor: 4.442

Review 2.  The pathophysiology of cancer-related fatigue: current controversies.

Authors:  C M O'Higgins; B Brady; B O'Connor; Declan Walsh; R B Reilly
Journal:  Support Care Cancer       Date:  2018-06-30       Impact factor: 3.603

3.  Randomized controlled trial of Qigong/Tai Chi Easy on cancer-related fatigue in breast cancer survivors.

Authors:  Linda K Larkey; Denise J Roe; Karen L Weihs; Roger Jahnke; Ana Maria Lopez; Carol E Rogers; Byeongsang Oh; Jose Guillen-Rodriguez
Journal:  Ann Behav Med       Date:  2015-04

Review 4.  Systematic review of the multidimensional fatigue symptom inventory-short form.

Authors:  Kristine A Donovan; Kevin D Stein; Morgan Lee; Corinne R Leach; Onaedo Ilozumba; Paul B Jacobsen
Journal:  Support Care Cancer       Date:  2014-08-22       Impact factor: 3.603

5.  Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia.

Authors:  Bangyan Wang; Sudip Thapa; Ting Zhou; Huiquan Liu; Lu Li; Guang Peng; Shiying Yu
Journal:  Support Care Cancer       Date:  2019-05-17       Impact factor: 3.603

6.  A Single Center Survey of Health-Related Quality of Life among Acute Myeloid Leukemia Survivors in First Complete Remission.

Authors:  M Jennifer Cheng; B Douglas Smith; Christopher S Hourigan; Ivana Gojo; Keith W Pratz; Amanda L Blackford; Ambereen K Mehta; Thomas J Smith
Journal:  J Palliat Med       Date:  2017-05-24       Impact factor: 2.947

Review 7.  Medical management of brain tumors and the sequelae of treatment.

Authors:  David Schiff; Eudocia Q Lee; Lakshmi Nayak; Andrew D Norden; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2014-10-30       Impact factor: 12.300

8.  Ginseng Purified Dry Extract, BST204, Improved Cancer Chemotherapy-Related Fatigue and Toxicity in Mice.

Authors:  Hyun-Jung Park; Hyun Soo Shim; Jeom Yong Kim; Joo Young Kim; Sun Kyu Park; Insop Shim
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-07       Impact factor: 2.629

Review 9.  Ginseng for the Management of Cancer-Related Fatigue: An Integrative Review.

Authors:  Emily A Lemke
Journal:  J Adv Pract Oncol       Date:  2021-05-01

10.  Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials.

Authors:  Julia Mo; Amy K Darke; Katherine A Guthrie; Jeff A Sloan; Joseph M Unger; Dawn L Hershman; Mark O'Rourke; Marie Bakitas; Robert S Krouse
Journal:  JCO Oncol Pract       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.